Thrilled to share our deconstruction of a p53 therapeutic response in #LUAD- a step toward drugging #undruggable #p53! Thanks to our amazing team and to Cancer Discovery @aacrjournals.bsky.social!
Latest posts tagged with #LUAD on Bluesky
Thrilled to share our deconstruction of a p53 therapeutic response in #LUAD- a step toward drugging #undruggable #p53! Thanks to our amazing team and to Cancer Discovery @aacrjournals.bsky.social!
#Research
Peripheral TERT- positive #leukocytes as a #biomarker of the local and systemic immune failure in early-stage lung adenocarcinoma progression doi.org/10.1186/s435...
#LungAdenocarcinoma #LUAD #Invasive #Adenocarcinoma #Immunosuppression
#Research
Identification of PIWI-interacting RNAs based models for lung adenocarcinoma early detection: a multicenter cohort study doi.org/10.1186/s435...
#LungAdenocarcinoma #LUAD #Piwi_interactingRNAs #EarlyDetection #NodulesStratification #MachineLearning
Two FRA-RIG-LUNG survival models for TCGA LUAD: one outcome-aware, one “honest” (no future leakage). Models, reports and sklearn code 📁 zenodo.org/records/1781...
#lungcancer #LUAD #TCGA #AIforHealth #bioinformatics #opensource #OpenData
#Alsky #MachineLearning #NeurosymbolicAI#BigData #Tech
#Article in #MedComm_Oncology
LncRNA SNHG5/miR-363-3p/USP28 Axis Promotes Lung Adenocarcinoma Progression Through Enhancing β-Catenin Stabilization doi.org/10.1002/mog2...
#lncRNA #LUAD #miR_363_3p #SNHG5 #USP28 #β_catenin #SingalingPathway
❄️ Don't miss our November Issue🌨️
📗 Cytomegalovirus (pp71-green) in primary prostate cancer (pan-keratin red)
📑 EACR Viewpoint on clinical KRAS/RAS inhibitors & novel strategies for RAS-mutant cancers @ciccancer.bsky.social
🔓 buff.ly/NpZSen9
#NSCLC #LUAD #Hypoxia #LungCancer
This study reveals that CSC-derived EVs deliver #lncRNA ROLLCSC to #LUAD cells by reshaping #LipidMetabolism & boosting #Ferroptosis resistance. #medsky
#OpenAccess:
www.sciencedirect.com/science/arti...
A comprehensive overview of the differences in genomic features, driver genes, & #epigenetic targets between #LUAD & LUSC, along with insights into distinct strategies & protocols for their clinical management. #medsky
#OpenAccess:
Summarizing the differences in genomic features, driver genes & #epigenetic targets between #LUAD & LUSC, and the distinct strategies & protocols emerging in #chemotherapy, targeted therapy, & #immunotherapy for the clinical management of LUAD & LUSC. #medsky
#OpenAccess:
buff.ly/sph33Eu
Happy to see that my PhD project reached its completion.
In this study, we uncover how tumor-intrinsic loss of SPHK1 fuels inflammation-driven progression in KRAS-mutated LUAD
🔍 If you're interested in inflammation and KRAS cancers check it out
#kras #LUAD
www.sciencedirect.com/science/arti...